Development of HLB3-002 (recombinant Human PH20 Stand-Alone) and Its Applicability As an Anticancer Diffusion Agent. Heeyoun Kim,Juyoung ByunJournal of Clinical Oncology(2024)引用 0|浏览3AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要